Use of gp130 activators in diabetic neuropathy
US7465441B2 · kind B2 · utility
0Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2002 |
| Grant date | Dec 16, 2008 |
| Priority date | — |
| Expiry date | Aug 5, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/10011
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use a substance signaling through gp130 for the manufacture of a medicament for the treatment and/or prevention of diabetic neuropathy. The use of IL-6 is preferred.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.